Literature DB >> 15269826

Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature.

Karin van Dijk1, Johanna G van der Bom, Kathelijn Fischer, Diederick E Grobbee, H Marijke van den Berg.   

Abstract

There is considerable variability in bleeding patterns of severe haemophilia (<1% factor VIII). Knowledge of the contribution of thrombophilic factors in these patterns may improve individually tailored treatment strategies. We reviewed the literature regarding the relation between prothrombotic factors and clinical phenotype of severe haemophilia. Medline and EMBASE were searched for relevant articles. 9369 articles published between 1963 and September 2003 were screened and seven relevant papers were retrieved. Each of these reported on a different combination of thrombophilic factors. Presence of the factor V Leiden mutation appears to decrease the severity of severe haemophilia most consistently. Findings on other thrombophilic factors were inconclusive. There is a clear need for additional research on potential determinants of phenotypes of severe haemophilia before such knowledge can be translated into individual care for severe haemophilia patients with confidence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269826     DOI: 10.1160/TH04-02-0112

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

Review 1.  Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature.

Authors:  A Girolami; F Tezza; M Scapin; S Vettore; A Casonato
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 2.  The hemostatic balance revisited through the lessons of mankind evolution.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2008-02-19       Impact factor: 3.397

Review 3.  Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases.

Authors:  Antonio Girolami; Raffaella Scandellari; Ezio Zanon; Roberto Sartori; Bruno Girolami
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

Review 4.  Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.

Authors:  B A Konkle; J M Johnsen; M Wheeler; C Watson; M Skinner; G F Pierce
Journal:  Haemophilia       Date:  2018-05       Impact factor: 4.287

5.  Impact of Prothrombotic Risk Factors in a Cohort of Egyptian Hemophilia A Patients.

Authors:  Mona Salah El-Din Hamdy; Aml Soliman Nasr; Manal Mohamed Makhlouf; Zainab Ali El-Saadany; Magy Samir; Dalia Saber Morgan
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

6.  Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

Authors:  Connie Duckers; Paolo Simioni; Luca Spiezia; Claudia Radu; Sabrina Gavasso; Jan Rosing; Elisabetta Castoldi
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

Review 7.  Novel therapies and current clinical progress in hemophilia A.

Authors:  Pauline Balkaransingh; Guy Young
Journal:  Ther Adv Hematol       Date:  2017-12-28

8.  Clot stability as a determinant of effective factor VIII replacement in hemophilia A.

Authors:  L Leong; I N Chernysh; Y Xu; D Sim; C Nagaswami; Z de Lange; S Kosolapova; A Cuker; K Kauser; J W Weisel
Journal:  Res Pract Thromb Haemost       Date:  2017-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.